Navigation Links
CEL-SCI Corporation Announces 2007 Financial Results
Date:1/14/2008

As opposed to other immunotherapies which are designed to target a single or limited number of specific antigens or molecules, Immune SIMULATORS are multi-targeted; they simultaneously cause a direct and targeted killing of the specific tumor cells and they activate the immune system to produce a stronger anti-tumor attack on multiple fronts.

Multikine is also the first immunotherapeutic agent being developed as a first-line standard of care treatment for cancer. It is administered prior to any other cancer therapy because that is the period when the anti-tumor immune response can still be fully activated. Once the patient has advanced disease, or had surgery or has received radiation and/or chemotherapy, the immune system is severely weakened and is less able to mount an effective anti-tumor immune response. Other immunotherapies are administered after the patient has received chemotherapy and/or radiation therapy, which can limit their effectiveness.

The Company has operations in Vienna, Virginia and Baltimore, Maryland. CEL-SCI's other products, which are currently in pre-clinical stage, have shown protection against a number of diseases in animal tests and are being tested against diseases associated with bio-defense.

CEL-SCI CORPORATION

CONSOLIDATED STATEMENTS OF OPERATIONS

YEARS ENDED SEPTEMBER 30, 2007 and 2006

2007 2006

GRANT REVENUE AND OTHER $ 57,043 $ 125,457

OPERATING EXPENSES:

Research and development (excluding

R&D depreciation of $91,292, $74,043

and $96,442 respectively, included

below) 2,528,528 1,896,976

Depreciation and amortization 176,186 170,903

General & administrative 6,704,538 3,406,774


'/>"/>
SOURCE CEL-SCI Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation
2. CEL-SCI to Present at Rodman & Renshaw 9th Annual Healthcare Conference
3. CEL-SCI CEO to Present at the International Society for Pharmaceutical Engineering 2007 Chesapeake BioShowcase
4. CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein
5. CEL-SCI CEO to Present Tomorrow at the Biotech / Pharma / Healthcare On-Line Forum
6. CEL-SCI Corporation Releases Letter to Shareholders
7. CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug
8. Berkery Noyes Represented The Thomson Corporation in the Sale of CenterWatch and New England Institutional Review Board to Jobson Medical Information
9. AmpliMed Corporation Announces Promising 1-year Survival Data from Phase I/II Study of Amplimexon(R) in Metastatic Malignant Melanoma
10. Immunosyn Corporation Releases SF-1019 Study Results
11. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... -- Does your doctor know what you,re smoking?  Chances are, ... to the over 112,000 currently registered patients under ... other roughly 20,300+ active physicians listed with the Colorado Dept ... even though a poll in February 2014 showed 51% of ... it. "With marijuana legalization underway, every doctor ...
(Date:8/29/2014)... Md. , Aug. 29, 2014  United Therapeutics ... the U.S. District Court for the District of ... favor in the company,s case against Sandoz, Inc. regarding ... Peter Sheridan ruled that U.S. Patent No. ... and enjoined Sandoz from marketing its generic product until ...
(Date:8/29/2014)... , August 29, 2014 ... Market by Product & Services (Equipment, Reagent, Primer, ... Application (Diagnostics, PCR, QPCR, Gene Synthesis, NGS, DNA, ... MarketsandMarkets, the global Oligonucleotide Synthesis Market is expected ... Million in 2014, growing at a CAGR of ...
Breaking Medicine Technology:Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 3Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 4District Court Decision Received In Remodulin Patent Case 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 3Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 4
(Date:8/30/2014)... Bringing forth the great opportunities, India's ... Labor Day discount on all SEO services. While working ... services related to internet marketing. Their dedicated team of ... do have a deep understanding for their specialization. This ... and since the inception, they have worked with over ...
(Date:8/30/2014)... PA (PRWEB) August 30, 2014 "I had ... because of her crutches," said an inventor from Wetumpka, Ala. ... sights and sounds of the shore, I came up with ... sand." , She created a prototype for the patent-pending Deezers ... accessory enables the individual to use crutches, walkers, or canes ...
(Date:8/30/2014)... In today’s world, a good night’s sleep has become especially ... (a medical problem where the airway collapses during sleep and ... rest they need to face their daily challenges. , ... people in the United States alone have sleep apnea. Of ... those treated, many cannot tolerate their prescribed medical device known ...
(Date:8/30/2014)... One of the most recent dietary trends to have ... meant for sufferers of gluten intolerance and celiac disease, the ... looking to get healthier by simply consuming foods which are ... information erroneous, it also exposes those same consumers to ... change in their food consumption habits. , Because ...
(Date:8/30/2014)... 2014 The new review published by Daily ... by Karen Brimeyer, who wanted to make her guide accessible ... guide is now easy to find in the form of ... guide, the author of the new method shares all her ... Gossip writes in its review that the leaky gut syndrome ...
Breaking Medicine News(10 mins):Health News:Profit By Search Announces Labor Day Discount on SEO Services 2Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3Health News:“What is Gluten: Three Things You Need to Know Before Adopting a Gluten-Free Diet” Reveals What Readers Need to Know About the Benefits of a Strict Gluten Diet - Vinamy 2Health News:Leaky Gut Cure Review Reveals Unique Method to Stop Chronic Symptoms 2
... of the problem , , THURSDAY, June 19 (HealthDay News) ... of an oral rapid HIV test was recently halted ... Mental Hygiene, which operates 10 sexually transmitted disease walk-in ... rapid HIV testing of finger-stick, whole-blood specimens using the ...
... or both might be the culprit, experts say , , THURSDAY, ... keeping infected individuals alive and relatively healthy for years, even ... emerging for these long-term survivors: increased odds for heart attack ... the virus itself or the drugs used to treat it, ...
... Los Angeles, London, New Delhi, Singapore (June 19, 2008) ... a uniform referral process are leaving Ontario physicians brokering ... knee replacement, a study led by a St. Michael,s ... Research has revealed. The variability in this process means ...
... reveals in detail how breast cells produce new cells that ... action of the CHFR gene. , CHFR expression is ... of this gene is also a hot area of interest ... forms of cancer. , The new study reveals how ...
... Va. Chief of Naval Research (CNR) Rear Admiral William ... innovative ideas brought to the Office of Naval Research (ONR) ... (12-14 August) at the Marriott Wardman Park Hotel in Washington, ... preeminent science and technology organization, recognized both inside and outside ...
... June 19 Agendia BV has,announced the official ... Science Park at Watergraafsmeer, Kruislaan 406. The Grand,Opening ... Scientific,Officer at Agendia and the Honourable Director General ... Maria van der Hoeven, Minster of Economic,Affairs for ...
Cached Medicine News:Health News:False Positives in Oral HIV Test Halt Use in NYC 2Health News:Heart Risks Emerging in People With HIV 2Health News:Heart Risks Emerging in People With HIV 3Health News:System constraints forcing Canadian physicians to become medical brokers in prioritizing 2Health News:Lack of CHFR gene expression sets stage for breast cancer 2Health News:Lack of CHFR gene expression sets stage for breast cancer 3Health News:ONR offers up to $1M for innovative science and technology ideas 2Health News:Agendia Expands Laboratory Capacity at New Amsterdam Headquarters to Meet Increasing Demand for Services Worldwide 2
The Linvatec UltraFix Suture Anchor System's smooth surface until deployed eliminates tissue, bone and suture damage and its ultra smooth eyelet hole preserves suture integrity....
... The requirements for Bi-Plane Electrophysiology imaging have ... decrease procedure time and reduce radiation exposure ... paramount in deciding between Single and Bi-Plane ... of maintaining its leadership position in price/value ...
... Millbrook Practice Manager® is now known ... (PM). Centricity Physician Office - PM is ... and structure, providing an easily adaptable solution ... physician offices of every specialty and ...
... PrimeChart™ is the Point-of Care Electronic ... for an automated encounter documentation process and ... to use interface that is both mobile ... interface technologies, such as pentop technology with ...
Medicine Products: